Camellia sinensis in asymptomatic hyperuricemia: A meta-analysis of tea or tea extract effects on uric acid levels

References

• Axling, U., Olsson, C., Xu, J., Fernandez, C., Larsson, S., Ström, K., Ahrné, S., Holm, C., Molin, G. and Berger, K. (2012). Green tea powder and Lactobacillus plantarum affect gut microbiota, lipid metabolism and inflammation in high-fat fed C57BL/6J mice. Nutr. Metab. (Lond). 9(1):105.
   PubMed Web of Science ®Google Scholar
• Bahorun, T., Luximon-Ramma, A., Gunness, T. T., Sookar, D., Bhoyroo, S., Jugessur, R., Reebye, D., Googoolye, K., Crozier, A. and Aruoma, O. O. (2010). Black tea reduces uric acid and C-reactive protein levels in humans susceptible to cardiovascular diseases. Toxicology 278(1):68–74.
   PubMed Web of Science ®Google Scholar
• Becker, M. M. and Jolly, M. (2006). Hyperuricemia and associated diseases. Rheum. Dis. Clin. North Am. 32(2):275–293.
   PubMed Web of Science ®Google Scholar
• Calder, P. P., Ahluwalia, N., Brouns, F., Buetler, T., Clement, K., Cunningham, K., Esposito, K., Jönsson, L. L., Kolb, H., Lansink, M., Marcos, A., Margioris, A., Matusheski, N., Nordmann, H., O'Brien, J., Pugliese, G., Rizkalla, S., Schalkwijk, C., Tuomilehto, J., Wärnberg, J., Watzl, B. and Winklhofer-Roob, B. B. (2011). Dietary factors and low-grade inflammation in relation to overweight and obesity. Br. J. Nutr. 106(3):S5–S78.
   PubMed Web of Science ®Google Scholar
• Chow, H. H., Cai, Y., Hakim, I. I., Crowell, J. J., Shahi, F., Brooks, C. C., Dorr, R. R., Hara, Y. and Alberts, D. D. (2003). Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin. Cancer Res. 9(9):3312–3319.
   PubMed Web of Science ®Google Scholar
• Chow, H. H., Hakim, I. I., Vining, D. D., Crowell, J. J., Cordova, C. C., Chew, W. W., Xu, M. M., Hsu, C. C., Ranger-Moore, J. and Alberts, D. D. (2006). Effects of repeated green tea catechin administration on human cytochrome P450 activity. Cancer Epidemiol. Biomarkers. Prev. 15(12):2473–2476.
   PubMed Web of Science ®Google Scholar
• Chow, H. H., Hakim, I. I., Vining, D. D., Crowell, J. J., Tome, M. M., Ranger-Moore, J., Cordova, C. C., Mikhael, D. D., Briehl, M. M., and Alberts, D. D. (2007). Modulation of human glutathione s-transferases by polyphenon e intervention. Cancer Epidemiol. Biomarkers. Prev. 16(8):1662–1666.
   PubMed Web of Science ®Google Scholar
• Dew, T. T., Day, A. A. and Morgan, M. M. (2005). Xanthine oxidase activity in vitro: Effects of food extracts and components. J. Agric. Food Chem. 53(16):6510–6515.
   PubMed Web of Science ®Google Scholar
• El-Sheikh, A. A., van den Heuvel, J. J., Koenderink, J. J. and Russel, F. F. (2008). Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4. Br. J. Pharmacol. 155(7):1066–1075.
   PubMed Web of Science ®Google Scholar
• Fink, H. H., Wilt, T. T., Eidman, K. K., Garimella, P. P., MacDonald, R., Rutks, I. I., Brasure, M., Kane, R. R., Ouellette, J. and Monga, M. (2013). Medical management to prevent recurrent nephrolithiasis in adults: A systematic review for an American College of Physicians Clinical Guideline. Ann. Intern. Med. 158(7):535–543.
   PubMed Web of Science ®Google Scholar
• Fuchikami, H., Satoh, H., Tsujimoto, M., Ohdo, S., Ohtani, H. and Sawada, Y. (2006). Effects of herbal extracts on the function of human organic anion-transporting polypeptide OATP-B. Drug. Metab. Dispos. 34(4):577–582.
   PubMed Web of Science ®Google Scholar
• Gomikawa, S., Ishikawa, Y., Hayase, W., Haratake, Y., Hirano, N., Matuura, H., Mizowaki, A., Murakami, A. and Yamamoto, M. (2008). Effect of ground green tea drinking for 2 weeks on the susceptibility of plasma and LDL to the oxidation ex vivo in healthy volunteers. Kobe. J. Med. Sci. 54(1):E62–E72.
   PubMedGoogle Scholar
• Han, S. S., Han, S. S., Toborek, M. and Hennig, B. (2012). EGCG protects endothelial cells against PCB 126-induced inflammation through inhibition of AhR and induction of Nrf2-regulated genes. Toxicol. Appl. Pharmacol. 261(2):181–188.
   PubMed Web of Science ®Google Scholar
• Henning, S. S., Niu, Y., Liu, Y., Lee, N. N., Hara, Y., Thames, G. G., Minutti, R. R., Carpenter, C. C., Wang, H. and Heber, D. (2005). Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals. J. Nutr. Biochem. 16(10):610–616.
   PubMed Web of Science ®Google Scholar
• Henning, S. S., Wang, P. and Heber, D. (2011). Chemopreventive effects of tea in prostate cancer: Green tea versus black tea. Mol. Nutr. Food Res. 55(6):905–920.
   PubMed Web of Science ®Google Scholar
• Hesse, A., Siener, R., Heynck, H. and Jahnen, A. (1993). The influence of dietary factors on the risk of urinary stone formation. Scann. Microsc. 7(3):1119–1127.
   PubMedGoogle Scholar
• Hooper, L. L., Littman, D. D. and Macpherson, A. A. (2012). Interactions between the microbiota and the immune system. Science. 336(6086):1268–1273.
   PubMed Web of Science ®Google Scholar
• Hsu, C. C., Liao, Y. Y., Lin, S. S., Tsai, T. T., Huang, C. C. and Chou, P. (2011). Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial. Altern. Med. Rev. 16(2):157–163.
   PubMed Web of Science ®Google Scholar
• Hsu, C. C., Tsai, T. T., Kao, Y. Y., Hwang, K. K., Tseng, T. T. and Chou, P. (2008). Effect of green tea extract on obese women: A randomized, double-blind, placebo-controlled clinical trial. Clin. Nutr. 27(3):363–370.
   PubMed Web of Science ®Google Scholar
• Hu, Q. Q., Wang, C., Li, J. J., Zhang, D. D. and Kong, L. L. (2009). Allopurinol, rutin, and quercetin attenuate hyperuricemia and renal dysfunction in rats induced by fructose intake: Renal organic ion transporter involvement. Am. J. Physiol. Renal. Physiol. 297(4):F1080–F1091.
   PubMed Web of Science ®Google Scholar
• Hu, Q. Q., Zhang, X., Wang, X., Jiao, R. R. and Kong, L. L. (2012). Quercetin regulates organic ion transporter and uromodulin expression and improves renal function in hyperuricemic mice. Eur. J. Nutr. 51(5):593–606.
   PubMed Web of Science ®Google Scholar
• Hwang, I. I., Suh, S. S., Suh, A. A. and Ahn, H. H. (2011). The relationship between normal serum uric acid and nonalcoholic fatty liver disease. J. Korean Med. Sci. 26(3):386–391.
   PubMed Web of Science ®Google Scholar
• Hwu, C. C. and Lin, K. K. (2010). Uric acid and the development of hypertension. Med. Sci. Monit. 16(10):RA224–RA230.
   PubMed Web of Science ®Google Scholar
• Itoh, Y., Yasui, T., Okada, A., Tozawa, K., Hayashi, Y. and Kohri, K. (2005). Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis. J. Urol. 173(1):271–275.
   PubMed Web of Science ®Google Scholar
• Jówko, E., Sacharuk, J., Balasinska, B., Wilczak, J., Charmas, M., Ostaszewski, P. and Charmas, R. (2012). Effect of a single dose of green tea polyphenols on the blood markers of exercise-induced oxidative stress in soccer players. Int. J. Sport Nutr. Exerc. Metab. 22(6):486–496.
   PubMed Web of Science ®Google Scholar
• Kanellis, J., Feig, D. D. and Johnson, R. R. (2004). Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed. Nephrology (Carlton). 9(6):394–399.
   PubMed Web of Science ®Google Scholar
• Kawamoto, R., Tabara, Y., Kohara, K., Kusunoki, T., Abe, M. and Miki, T. (2013). Serum uric acid is more strongly associated with impaired fasting glucose in women than in men from a community-dwelling population. PLoS One. 8(6):e65886.
   PubMed Web of Science ®Google Scholar
• Kimura, A., Ishida, Y., Hayashi, T., Wada, T., Yokoyama, H., Sugaya, T., Mukaida, N. and Kondo, T. (2006). Interferon-gamma plays protective roles in sodium arsenite-induced renal injury by up-regulating intrarenal multidrug resistance-associated protein 1 expression. Am. J. Pathol. 169(4):1118–1128.
   PubMed Web of Science ®Google Scholar
• Kimura, M., Umegaki, K., Kasuya, Y., Sugisawa, A. and Higuchi, M. (2002). The relation between single/double or repeated tea catechin ingestions and plasma antioxidant activity in humans. Eur. J. Clin. Nutr. 56(12):1186–1193.
   PubMed Web of Science ®Google Scholar
• Lahera, V., Goicoechea, M., de Vinuesa, S. S., Oubiña, P., Cachofeiro, V., Gómez-Campderá, F., Amann, R. and Luño, J. (2006). Oxidative stress in uremia: The role of anemia correction. J. Am. Soc. Nephrol. 7(12 Suppl 3):S174–S177.
   Web of Science ®Google Scholar
• Leenen, R., Roodenburg, A. A., Tijburg, L. L. and Wiseman, S. S. (2000). A single dose of tea with or without milk increases plasma antioxidant activity in humans. Eur. J. Clin. Nutr. 54(1):87–92.
   PubMed Web of Science ®Google Scholar
• Li, L., Chen, C. C., Aldini, G., Johnson, E. E., Rasmussen, H., Yoshida, Y., Niki, E., Blumberg, J. J., Russell, R. R. and Yeum, K. K. (2010). Supplementation with lutein or lutein plus green tea extracts does not change oxidative stress in adequately nourished older adults. J. Nutr. Biochem. 21(6):544–549.
   PubMed Web of Science ®Google Scholar
• Lin, J. J., Chen, P. P., Ho, C. C. and Lin-Shiau, S. S. (2000). Inhibition of xanthine oxidase and suppression of intracellular reactive oxygen species in HL-60 cells by theaflavin-3,3′-digallate, (−)-epigallocatechin-3-gallate, and propyl gallate. J. Agric. Food Chem. 48(7):2736–2743.
   PubMed Web of Science ®Google Scholar
• Liptrott, N. N., Penny, M., Bray, P. P., Sathish, J., Khoo, S. S., Back, D. D. and Owen, A. (2009). The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC. Br. J. Pharmacol. 156(3):497–508.
   PubMed Web of Science ®Google Scholar
• Łuczaj, W. and Skrzydlewska, E. (2005). Antioxidative properties of black tea. Prev. Med. 40(6):910–918.
   PubMed Web of Science ®Google Scholar
• Mandell, B. B. (2008). Clinical manifestations of hyperuricemia and gout. Cleve. Clin. J. Med. 75(Suppl 5):S5–S8.
   PubMedGoogle Scholar
• Markel, A. (2005). Allopurinol-induced DRESS syndrome. Isr. Med. Assoc. J. 7(10):656–660.
   PubMed Web of Science ®Google Scholar
• Maron, D. D., Lu, G. G., Cai, N. N., Wu, Z. Z., Li, Y. Y., Chen, H., Zhu, J. J., Jin, X. X., Wouters, B. B. and Zhao, J. (2003). Cholesterol-lowering effect of a theaflavin-enriched green tea extract: A randomized controlled trial. Arch. Intern. Med. 163(12):1448–1453.
   PubMed Web of Science ®Google Scholar
• Martinez-Hervas, S., Real, J. J., Ivorra, C., Priego, A., Chaves, F. F., Pallardo, F. F., Viña, J. J., Redon, J., Carmena, R. and Ascaso, J. J. (2010). Increased plasma xanthine oxidase activity is related to nuclear factor kappa beta activation and inflammatory markers in familial combined hyperlipidemia. Nutr. Metab. Cardiovasc. Dis. 20(10):734–739.
   PubMed Web of Science ®Google Scholar
• Mikuls, T. T., Farrar, J. J., Bilker, W. W., Fernandes, S. and Saag, K. K. (2005). Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: Results from the UK General Practice Research Database (GPRD). Rheumatol. (Oxford). 44(8):1038–1042.
   PubMed Web of Science ®Google Scholar
• Moher, D., Liberati, A., Tetzlaff, J., Altman, D. D., PRISMA Group. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 6:e1000097.
   PubMed Web of Science ®Google Scholar
• Müller, N., Ellinger, S., Alteheld, B., Ulrich-Merzenich, G., Berthold, H. H., Vetter, H. and Stehle, P. (2010). Bolus ingestion of white and green tea increases the concentration of several flavan-3-ols in plasma, but does not affect markers of oxidative stress in healthy non-smokers. Mol. Nutr. Food Res. 54(11):1636–1645.
   PubMed Web of Science ®Google Scholar
• Natella, F., Nardini, M., Giannetti, I., Dattilo, C. and Scaccini, C. (2002). Coffee drinking influences plasma antioxidant capacity in humans. J. Agric. Food Chem. 50(21):6211–6216.
   PubMed Web of Science ®Google Scholar
• Nomura, M., Ma, W., Chen, N., Bode, A. A. and Dong, Z. (2000). Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced NF-kappaB activation by tea polyphenols, (−)-epigallocatechin gallate and theaflavins. Carcinogenesis. 21(10):1885–1890.
   PubMed Web of Science ®Google Scholar
• Palermo, C. C., Westlake, C. C. and Gasiewicz, T. T. (2005). Epigallocatechin gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 kDa heat shock protein. Biochemistry. 44(13):5041–5052.
   PubMed Web of Science ®Google Scholar
• Panza, V. V., Wazlawik, E., Ricardo Schütz, G., Comin, L., Hecht, K. K. and da Silva, E. E. (2008). Consumption of green tea favorably affects oxidative stress markers in weight-trained men. Nutrition. 24(5):433–442.
   PubMed Web of Science ®Google Scholar
• Park, A. A. and Dong, Z. (2003). Signal transduction pathways: Targets for green and black tea polyphenols. J. Biochem. Mol. Biol. 36(1):66–77.
   PubMedGoogle Scholar
• Peluso, I., Raguzzini, A. and Serafini, M. (2013). Effect of flavonoids on circulating levels of TNF-α and IL-6 in humans: A systematic review and meta-analysis. Mol. Nutr. Food Res. 57(5):784–801.
   PubMed Web of Science ®Google Scholar
• Princen, H. H., van Duyvenvoorde, W., Buytenhek, R., Blonk, C., Tijburg, L. L., Langius, J. J., Meinders, A. A. and Pijl, H. (1998). No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arterioscler. Thromb. Vasc. Biol. 18(5):833–841.
   PubMed Web of Science ®Google Scholar
• Rabovsky, A., Cuomo, J. and Eich, N. (2006). Measurement of plasma antioxidant reserve after supplementation with various antioxidants in healthy subjects. Clin. Chim. Acta. 371(1–2):55–60.
   PubMed Web of Science ®Google Scholar
• Rodrigues, S. S., Baldo, M. M., Capingana, P., Magalhães, P., Dantas, E. E., Molina Mdel, C., Salaroli, L. L., Morelato, R. R. and Mill, J. J. (2012). Gender distribution of serum uric acid and cardiovascular risk factors: Population based study. Arq. Bras. Cardiol. 98(1):13–21.
   PubMed Web of Science ®Google Scholar
• Rondanelli, M., Opizzi, A., Solerte, S. S., Trotti, R., Klersy, C. and Cazzola, R. (2009). Administration of a dietary supplement (N-oleyl-phosphatidylethanolamine and epigallocatechin-3-gallate formula) enhances compliance with diet in healthy overweight subjects: A randomized controlled trial. Br. J. Nutr. 101(3):457–464.
   PubMed Web of Science ®Google Scholar
• Roth, M., Timmermann, B. B. and Hagenbuch, B. (2011). Interactions of green tea catechins with organic anion-transporting polypeptides. Drug. Metab. Dispos. 39(5):920–926.
   PubMed Web of Science ®Google Scholar
• Sekine, T., Miyazaki, H. and Endou, H. (2006). Molecular physiology of renal organic anion transporters. Am. J. Physiol. Renal. Physiol. 290(2):F251–F261.
   PubMed Web of Science ®Google Scholar
• Serafini, M., Del Rio, D., Yao, D. D., Bettuzzi, S. and Peluso, I. (2011a). Health benefits of tea. In: Herbal Medicine: Biomolecular and Clinical Aspects. 2nd ed. Chapter 12. pp. 239–262. Benzie, I. F. F. and Wachtel-Galor, S., Eds., CRC Press, Boca Raton, FL.
   Google Scholar
• Serafini, M., Miglio, C., Peluso, I. and Petrosino, T. (2011b) Modulation of plasma non enzimatic antioxidant capacity (NEAC) by plant foods: The role of polyphenols. Curr. Top. Med. Chem. 11(14):1821–1846.
   PubMed Web of Science ®Google Scholar
• Shi, Y., Evans, J. J. and Rock, K. K. (2003). Molecular identification of a danger signal that alerts the immune system to dying cells. Nature. 425:516–521.
   PubMed Web of Science ®Google Scholar
• Sone, T., Kuriyama, S., Nakaya, N., Hozawa, A., Shimazu, T., Nomura, K., Rikimaru, S. and Tsuji, I. (2011). Randomized controlled trial for an effect of catechin-enriched green tea consumption on adiponectin and cardiovascular disease risk factors. Food Nutr. Res. 55. doi: 10.3402/fnr.v55i0.8326.
   PubMed Web of Science ®Google Scholar
• Strazzullo, P. and Puig, J. J. (2007). Uric acid and oxidative stress: Relative impact on cardiovascular risk? Nutr. Metab. Cardiovasc. Dis. 17(6):409–414.
   PubMed Web of Science ®Google Scholar
• Sugihara, K., Kitamura, S., Yamada, T., Ohta, S., Yamashita, K., Yasuda, M. and Fujii-Kuriyama, Y. (2001). Aryl hydrocarbon receptor (AhR)-mediated induction of xanthine oxidase/xanthine dehydrogenase activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem. Biophys. Res. Commun. 281(5):1093–1099.
   PubMed Web of Science ®Google Scholar
• Tausche, A. A., Jansen, T. T., Schröder, H. H., Bornstein, S. S., Aringer, M. and Müller-Ladner, U. (2009). Gout–current diagnosis and treatment. Dtsch. Arztebl. Int. 106(34–35):549–555.
   PubMed Web of Science ®Google Scholar
• Tayar, J. J., Lopez-Olivo, M. M. and Suarez-Almazor, M. M. (2012). Febuxostat for treating chronic gout. Cochrane. Database Syst. Rev. 11:CD008653.
   PubMedGoogle Scholar
• Taylor, E. E. and Curhan, G. G. (2006). Diet and fluid prescription in stone disease. Kidney Int. 70(5):835–839.
   PubMed Web of Science ®Google Scholar
• Tremaroli, V. and Bäckhed, F. (2012). Functional interactions between the gut microbiota and host metabolism. Nature. 489(7415):242–249.
   PubMed Web of Science ®Google Scholar
• Vaidyanathan, J. J. and Walle, T. (2001). Transport and metabolism of the tea flavonoid (−)-epicatechin by the human intestinal cell line Caco-2. Pharm. Res. 18(10):1420–1425.
   PubMed Web of Science ®Google Scholar
• Van Amelsvoort, J. J., Van Hof, K. K., Mathot, J. J., Mulder, T. T., Wiersma, A. and Tijburg, L. L. (2001). Plasma concentrations of individual tea catechins after a single oral dose in humans. Xenobiotica. 31(12):891–901.
   PubMed Web of Science ®Google Scholar
• van het Hof, K. K., de Boer, H. H., Wiseman, S. S., Lien, N., Westrate, J. J. and Tijburg, L. L. (1997). Consumption of green or black tea does not increase resistance of low-density lipoprotein to oxidation in humans. Am. J. Clin. Nutr. 66(5):1125–1132.
   PubMed Web of Science ®Google Scholar
• Vischini, G., Niscola, P., Stefoni, A. and Farneti, F. (2011). Increased plasma levels of tacrolimus after ingestion of green tea. Am. J. Kidney Dis. 58(2):329.
   PubMed Web of Science ®Google Scholar
• Wang, C. C., Wang, X., Zhang, X., Shi, Y. Y., Liu, L. and Kong, L. L. (2010). Morin improves urate excretion and kidney function through regulation of renal organic ion transporters in hyperuricemic mice. J. Pharm. Pharm. Sci. 13(3):411–427.
   PubMed Web of Science ®Google Scholar
• Wang, H., Wei, Y., Kong, X. and Xu, D. (2013). Effects of urate-lowering therapy in hyperuricemia on slowing the progression of renal function: A meta-analysis. J. Ren. Nutr. 23(5):389–396.
   Web of Science ®Google Scholar
• Yin, Z., Henry, E. E. and Gasiewicz, T. T. (2009). (−)-Epigallocatechin-3-gallate is a novel Hsp90 inhibitor. Biochemistry. 48(2):336–345.
   PubMed Web of Science ®Google Scholar
• Yokozawa, T., Rhyu, D. D. and Cho, E. E. (2004). (−)-Epicatechin 3-O-gallate ameliorates the damages related to peroxynitrite production by mechanisms distinct from those of other free radical inhibitors. J. Pharm. Pharmacol. 56(2):231–239.
   PubMed Web of Science ®Google Scholar
• Yu, Z., Fong, W. W. and Cheng, C. C. (2007). Morin (3,5,7,2′,4′-pentahydroxyflavone) exhibits potent inhibitory actions on urate transport by the human urate anion transporter (hURAT1) expressed in human embryonic kidney cells. Drug. Metab. Dispos. 35(6):981–986.
   PubMed Web of Science ®Google Scholar
• Zhang, M. M., Gao, Y. Y., Wang, X., Chang, H. and Huang, G. G. (2013). Serum uric acid and appropriate cutoff value for prediction of metabolic syndrome among Chinese adults. J. Clin. Biochem. Nutr. 52(1):38–42.
   PubMed Web of Science ®Google Scholar
• Zoppini, G., Targher, G. and Bonora, E. (2011). The role of serum uric acid in cardiovascular disease in type 2 diabetic and non-diabetic subjects: A narrative review. J. Endocrinol. Invest. 34(11):881–886.
   PubMed Web of Science ®Google Scholar